Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.

Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, Maggioni M, Fracanzani AL, Fargion S.

J Hepatol. 2010 Nov;53(5):927-33. doi: 10.1016/j.jhep.2010.05.023.

PMID:
20739079
2.

Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.

Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S.

Hepatology. 2006 Oct;44(4):857-64.

PMID:
17006922
3.

Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.

Sartori M, Andorno S, Pagliarulo M, Rigamonti C, Bozzola C, Pergolini P, Rolla R, Suno A, Boldorini R, Bellomo G, Albano E.

Gut. 2007 May;56(5):693-8.

4.

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S.

Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013.

PMID:
19931264
5.

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL.

Haematologica. 2007 Aug;92(8):1037-42.

6.

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.

Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S.

PLoS One. 2012;7(11):e48804. doi: 10.1371/journal.pone.0048804.

7.

HFE genotype in patients with hemochromatosis and other liver diseases.

Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK.

Ann Intern Med. 1999 Jun 15;130(12):953-62.

PMID:
10383365
8.

Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.

Negro F, Samii K, Rubbia-Brandt L, Quadri R, Male PJ, Zarski JP, Baud M, Giostra E, Beris P, Hadengue A.

J Med Virol. 2000 Jan;60(1):21-7.

PMID:
10568758
9.

H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.

Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R.

Haematologica. 2002 Mar;87(3):242-5.

10.

[Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].

Skowron F, Bérard F, Grézard P, Wolf F, Morel Y, Perrot H.

Ann Dermatol Venereol. 2001 May;128(5):600-4. French.

11.

Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

Mayr R, Janecke AR, Schranz M, Griffiths WJ, Vogel W, Pietrangelo A, Zoller H.

J Hepatol. 2010 Nov;53(5):941-9. doi: 10.1016/j.jhep.2010.05.016.

12.

Liver pathology in compound heterozygous patients for hemochromatosis mutations.

Schöniger-Hekele M, Müller C, Polli C, Wrba F, Penner E, Ferenci P.

Liver. 2002 Aug;22(4):295-301.

PMID:
12296962
13.

H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?

de Diego C, Opazo S, Murga MJ, Martínez-Castro P.

Eur J Haematol. 2007 Jan;78(1):66-71.

PMID:
17042772
14.

Serum ferritin and transferrin saturation levels in β⁰ and β(+) thalassemia patients.

Estevão IF, Peitl Junior P, Bonini-Domingos CR.

Genet Mol Res. 2011 Apr 12;10(2):632-9. doi: 10.4238/vol10-2gmr1016.

15.

Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.

Lecube A, Hernández C, Simó R.

Diabetes Metab Res Rev. 2009 Jul;25(5):403-10. doi: 10.1002/dmrr.972. Review.

PMID:
19444865
16.

Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.

Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N; National Hemochromatosis Transplant Registry..

Gastroenterology. 2005 Aug;129(2):494-503.

PMID:
16083706
17.

Putative hemochromatosis gene mutations and alcoholic liver disease with iron overload in Japan.

Sohda T, Takeyama Y, Irie M, Kamimura S, Shijo H.

Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):21S-23S.

PMID:
10235273
18.

Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis.

Wallace DF, Clark RM, Harley HA, Subramaniam VN.

J Hepatol. 2004 Apr;40(4):710-3.

PMID:
15030991
19.

Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Raszeja-Wyszomirska J, Kurzawski G, Lawniczak M, Miezynska-Kurtycz J, Lubinski J.

World J Gastroenterol. 2010 May 28;16(20):2531-6.

20.

Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).

Cazzola M, Cremonesi L, Papaioannou M, Soriani N, Kioumi A, Charalambidou A, Paroni R, Romtsou K, Levi S, Ferrari M, Arosio P, Christakis J.

Br J Haematol. 2002 Nov;119(2):539-46.

PMID:
12406098

Supplemental Content

Support Center